Posted on April 24th, 2015
Craig A. Dionne, PhD, is one of GenSpera's founders and has served on our board since November 2003.
Company OverviewGenSpera unlocks conventional thinking to conceive, design, and develop curative cancer therapies that are core to the principles of finding the best way to cure or extend human life. Its innovative approach to drug delivery is expected to maximize anti-tumor activity and minimize side effects. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. GenSpera's lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the blood vessels of liver and glioblastoma cancers and in the blood vessels of almost all other solid tumors. Mipsagargin is therefore expected to have potential efficacy in a wide variety of tumor types. The US Food and Drug Administration (FDA) granted Orphan Drug designation in 2013 for the evaluation of mipsa... Learn More »
With the Bio Asia meeting in perspective, I can say that the time spent there was as promising as I had hoped and the ta...Read More »
Posted on April 21st, 2015
“Developing drugs for rare diseases starting with conditions that affect the kidneys.” You can find this statement...Read More »
Posted on April 7th, 2015
“It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness…” A ...Read More »
Posted on March 26th, 2015
The goal of my blog posting today is to provide an overview of the status of our Diagnostics and Therapeutics business u...Read More »
Posted on March 24th, 2015
Yesterday was my first full day at BIO Asia, the premier biotech event in Asia. While still early, it is already shaping...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »